Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Elucent Medical

Request full access

New idea in breast cancer treatment that exists to bring better healthcare ideas

Eden Prairie, United StatesFounded 2014Health Tech & Medtech

About Elucent Medical

Elucent Medical, Inc. is a medical technology company focused on developing surgical navigation solutions to improve outcomes in oncologic procedures. Founded in 2013 and headquartered in Eden Prairie, Minnesota, the company was established by a team with a successful track record in the med-tech space, including individuals from the former NeuWave Medical. The founding team includes Dr. Lee Wilke, a professor of surgery and director of the UW Health Breast Center; Fred Lee, a professor of imaging science; and Dan Van der Weide, an engineering professor. The impetus for the company came from Dr. Wilke, who identified the need for a more precise and less invasive method for locating tumors during breast-conserving surgery, aiming to replace traditional hook-wire localization techniques.

Elucent Medical operates in the surgical devices market, providing its technology to hospitals and surgical centers. Its business model centers on the sale of its integrated surgical guidance system and the associated disposable components. The company targets surgeons, particularly those specializing in breast cancer, with plans to expand into thoracic and other soft tissue applications. The company has secured significant funding to support its commercialization and development efforts, including a $42.5 million Series C round in April 2024.

The company's core offering is the EnVisio™ Surgical Navigation System, which utilizes In-Body Spatial Intelligence (iSI) to provide real-time, 3D guidance during surgery. This system works in conjunction with the SmartClip®, a permanently implantable, wireless soft tissue marker. The SmartClip can be placed at the time of biopsy to mark a lesion. During surgery, the EnVisio system, which includes a SmartSensor™ that attaches to standard surgical instruments and a SmartSurface™ that generates a spatial field, tracks the SmartClip's location, providing the surgeon with continuous data on the tumor's distance, depth, and direction. This allows for precise navigation to the tumor, aiming to minimize the removal of healthy tissue, reduce the likelihood of needing a second surgery due to positive margins, and eliminate the often uncomfortable pre-surgical hook-wire placement procedure for patients. The system received FDA 510(k) clearance in 2019 and has since been used in thousands of procedures. More recently, the company received an FDA Breakthrough Device Designation for its next-generation EnVisio X1 system, which is in development for broader soft tissue applications, including video- and robotic-assisted surgeries.

Source: Dealroom company data

At a glance

Status
Operational
Employees
126
Open positions
None listed
Dealroom signal
83.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Oncology, Surgery, Spinout, Woman Founder, DT and LS, science-based
Technology
Deep Tech
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Jan 2025 $30M — Trinity Capital ↗
SERIES COther financing Apr 2024 $43M $170M Vensana Capital · RC Capital ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Elucent Medical website traffic

Latest recorded traffic for Elucent Medical is 4.3K monthly website visits, up 168.8% over the last three months. Elucent Medical's team grew 5.9% over the past year.

Latest monthly visits4.3K 3-month web change+168.8% 1-year team growth+5.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
GreenBoneGreenBone Ortho aims to be a leading bone regenerative company that provides innovative, cost-effective, and easy-to-use solutions inspired by nature to cure severe orthopedic and bone diseases Faenza, Italy Operational 23 $26M $44M
HistoSonicsNon-invasive tumor destruction using focused ultrasound Minneapolis, United States Acquired
PeptomycFoundational anti-MYC mini-proteins for cancer treatment Barcelona, Spain Operational
Hangzhou Ruidi BiotechnologyA high-tech enterprise in the field of biomedicine integrating the research and development and sales of high-end medical device products Hangzhou, China Operational
Cairn SurgicalInnovative breast cancer surgery tools enhancing precision and reducing positive margins for better patient outcomes Lebanon, United States Operational
LeadoptikBuilding a miniature imaging platform to empower minimally invasive interventions with 3d navigation and high-resolution imaging in real-time Milpitas, United States Operational
Clarix ImagingSpecimen imaging for breast cancer surgery, providing unparalleled 3D visualization of lumpectomy specimens with VSI-360™, improving the correlation between interpretation and surgical pathology, and supported by decades Chicago, United States Operational
Lucida MedicalAI-powered MRI analysis for prostate cancer detection Cambridge, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Elucent Medical in the Eden Prairie ecosystem

Live from Dealroom

The Elucent Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Venture Investors Health Fund

Series B and later3 investors entered at this stage

  • Vensana Capital
  • RC Capital
  • Trinity Capital

Other known investors2 additional known investors

  • University of Wisconsin-Madison
  • WARF Ventures
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Elucent Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Elucent Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.